Stoddart, L. A., Smith, N. J. & Milligan, G. International Union of Pharmacology. LXXI. Free fatty acid receptors FFA1, -2, and -3: pharmacology and pathophysiological functions. Pharmacol. Rev. 60, 405–417 (2008).
Alvarez-Curto, E. & Milligan, G. Metabolism meets immunity: the role of free fatty acid receptors in the immune system. Biochem. Pharmacol. 114, 3–13 (2016).
Kimura, I., Ichimura, A., Ohue-Kitano, R. & Igarashi, M. Free fatty acid receptors in health and disease. Physiol. Rev. 100, 171–210 (2020).
McCarville, J. L., Chen, G. Y., Cuevas, V. D., Troha, K. & Ayres, J. S. Microbiota metabolites in health and disease. Annu. Rev. Immunol. 38, 147–170 (2020).
Zhou, Q. et al. Common activation mechanism of class A GPCRs. eLife 8, e50279 (2019).
Milligan, G., Shimpukade, B., Ulven, T. & Hudson, B. D. Complex pharmacology of free fatty acid receptors. Chem. Rev. 117, 67–110 (2017).
Maslowski, K. M. et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461, 1282–1286 (2009).
Kimura, I. et al. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat. Commun. 4, 1829 (2013).
Zhao, Y. et al. GPR43 mediates microbiota metabolite SCFA regulation of antimicrobial peptide expression in intestinal epithelial cells via activation of mTOR and STAT3. Mucosal Immunol. 11, 752–762 (2018).
Antunes, K. H. et al. Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response. Nat. Commun. 10, 3273 (2019).
Kimura, I., Inoue, D., Hirano, K. & Tsujimoto, G. The SCFA receptor GPR43 and energy metabolism. Front. Endocrinol. 5, 85 (2014).
Bindels, L. B., Dewulf, E. M. & Delzenne, N. M. GPR43/FFA2: physiopathological relevance and therapeutic prospects. Trends Pharmacol. Sci. 34, 226–232 (2013).
Huang, S. et al. Lithium carbonate alleviates colon inflammation through modulating gut microbiota and Treg cells in a GPR43-dependent manner. Pharmacol. Res. 175, 105992 (2022).
Park, B. O. et al. Novel GPR43 agonists exert an anti-Inflammatory effect in a colitis model. Biomol. Ther. 30, 48–54 (2022).
Hansen, A. H. et al. Discovery of a potent thiazolidine free fatty acid receptor 2 agonist with favorable pharmacokinetic properties. J. Med. Chem. 61, 9534–9550 (2018).
Lee, T. et al. Identification and functional characterization of allosteric agonists for the G protein-coupled receptor FFA2. Mol. Pharmacol. 74, 1599–1609 (2008).
Smith, N. J. et al. Extracellular loop 2 of the free fatty acid receptor 2 mediates allosterism of a phenylacetamide ago-allosteric modulator. Mol. Pharmacol. 80, 163–173 (2011).
Milligan, G., Bolognini, D. & Sergeev, E. in Free Fatty Acid Receptors (eds Milligan, G. & Kimura, I) 17–32 (Springer, 2017).
Bolognini, D. et al. A novel allosteric activator of free fatty acid 2 receptor displays unique Gi-functional bias. J. Biol. Chem. 291, 18915–18931 (2016).
Park, B. O. et al. The short-chain fatty acid receptor GPR43 modulates YAP/TAZ via RhoA. Mol. Cells 44, 458–467 (2021).
Zhang, X. et al. Structural basis for the ligand recognition and signaling of free fatty acid receptors. Sci. Adv. 10, eadj2384 (2024).
Li, F. et al. Molecular recognition and activation mechanism of short-chain fatty acid receptors FFAR2/3. Cell Res. 34, 323–326 (2024).
Brown, A. J. et al. The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 278, 11312–11319 (2003).
Hudson, B. D. et al. Chemically engineering ligand selectivity at the free fatty acid receptor 2 based on pharmacological variation between species orthologs. FASEB J. 26, 4951–4965 (2012).
Wang, Y. et al. The first synthetic agonists of FFA2: discovery and SAR of phenylacetamides as allosteric modulators. Bioorg. Med. Chem. Lett. 20, 493–498 (2010).
Lind, S. et al. Interdependent allosteric free fatty acid receptor 2 modulators synergistically induce functional selective activation and desensitization in neutrophils. Biochim. Biophys. Acta Mol. Cell. Res. 1867, 118689 (2020).
Olsen, R. H. J. et al. TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome. Nat. Chem. Biol. 16, 841–849 (2020).
Sergeev, E. et al. Non-equivalence of key positively charged residues of the free fatty acid 2 receptor in the recognition and function of agonist versus antagonist ligands. J. Biol. Chem. 291, 303–317 (2016).
Kim, K. et al. Structure of a hallucinogen-activated Gq-coupled 5-HT2A serotonin receptor. Cell 182, 1574–1588 (2020).
Xia, R. et al. Cryo-EM structure of the human histamine H1 receptor/Gq complex. Nat. Commun. 12, 2086 (2021).
Meyerowitz, J. G. et al. The oxytocin signaling complex reveals a molecular switch for cation dependence. Nat. Struct. Mol. Biol. 29, 274–281 (2022).
Nehme, R. et al. Mini-G proteins: novel tools for studying GPCRs in their active conformation. PLoS ONE 12, e0175642 (2017).
Wan, Q. et al. Mini G protein probes for active G protein-coupled receptors (GPCRs) in live cells. J. Biol. Chem. 293, 7466–7473 (2018).
Duan, J. et al. Cryo-EM structure of an activated VIP1 receptor–G protein complex revealed by a NanoBiT tethering strategy. Nat. Commun. 11, 4121 (2020).
Koehl, A. et al. Structure of the µ-opioid receptor–Gi protein complex. Nature 558, 547–552 (2018).
Swaminath, G. et al. Mutational analysis of G-protein coupled receptor—FFA2. Biochem. Biophys. Res. Commun. 405, 122–127 (2011).
Grundmann, M. et al. A molecular mechanism for sequential activation of a G protein-coupled receptor. Cell Chem. Biol. 23, 392–403 (2016).
Draper-Joyce, C. J. et al. Positive allosteric mechanisms of adenosine A1 receptor-mediated analgesia. Nature 597, 571–576 (2021).
Ballesteros, J. A. & Weinstein, H. in Methods in Neurosciences Vol. 25 (ed. Sealfon, S. C.) 366–428 (Academic Press, 1995).
Wang, Y., Yu, Z., Xiao, W., Lu, S. & Zhang, J. Allosteric binding sites at the receptor–lipid bilayer interface: novel targets for GPCR drug discovery. Drug Discov. Today 26, 690–703 (2021).
Ding, T., Karlov, D. S., Pino-Angeles, A. & Tikhonova, I. G. Intermolecular interactions in G protein-coupled receptor allosteric sites at the membrane interface from molecular dynamics simulations and quantum chemical calculations. J. Chem. Inf. Model. 62, 4736–4747 (2022).
Ciancetta, A. et al. Probe confined dynamic mapping for G protein-coupled receptor allosteric site prediction. ACS Cent. Sci. 7, 1847–1862 (2021).
Filipek, S. Molecular switches in GPCRs. Curr. Opin. Struct. Biol. 55, 114–120 (2019).
Barker, G. et al. 3-Substituted 2-amino-indole derivatives. WIPO patent WO2015/198045 (2015).
Weis, W. I. & Kobilka, B. K. The molecular basis of G protein-coupled receptor activation. Annu. Rev. Biochem. 87, 897–919 (2018).
Hauser, A. S. et al. GPCR activation mechanisms across classes and macro/microscales. Nat. Struct. Mol. Biol. 28, 879–888 (2021).
Manglik, A. & Kruse, A. C. Structural basis for G protein-coupled receptor activation. Biochemistry 56, 5628–5634 (2017).
Lu, J. et al. Structural basis for the cooperative allosteric activation of the free fatty acid receptor GPR40. Nat. Struct. Mol. Biol. 24, 570–577 (2017).
Ho, J. D. et al. Structural basis for GPR40 allosteric agonism and incretin stimulation. Nat. Commun. 9, 1645 (2018).
Powers, A. S. et al. A non-canonical mechanism of GPCR activation. Nat. Commun. 15, 9938 (2024).
Slosky, L. M., Caron, M. G. & Barak, L. S. Biased allosteric modulators: new frontiers in GPCR drug discovery. Trends Pharmacol. Sci. 42, 283–299 (2021).
Flock, T. et al. Selectivity determinants of GPCR–G-protein binding. Nature 545, 317–322 (2017).
Inoue, A. et al. Illuminating G-protein-coupling selectivity of GPCRs. Cell 177, 1933–1947 (2019).
Flock, T. et al. Universal allosteric mechanism for Gα activation by GPCRs. Nature 524, 173–179 (2015).
Bahia, D. S. et al. Hydrophobicity of residue351 of the G protein Gi1α determines the extent of activation by the α2A-adrenoceptor. Biochemistry 37, 11555–11562 (1998).
Manglik, A. & Kobilka, B. The role of protein dynamics in GPCR function: insights from the β2AR and rhodopsin. Curr. Opin. Cell Biol. 27, 136–143 (2014).
Hilger, D. The role of structural dynamics in GPCR-mediated signaling. FEBS J. 288, 2461–2489 (2021).
Zhuang, Y. et al. Mechanism of dopamine binding and allosteric modulation of the human D1 dopamine receptor. Cell Res. 31, 593–596 (2021).
Liu, X. et al. Mechanism of β2AR regulation by an intracellular positive allosteric modulator. Science 364, 1283–1287 (2019).
Liu, H. et al. Orthosteric and allosteric action of the C5a receptor antagonists. Nat. Struct. Mol. Biol. 25, 472–481 (2018).
Latorraca, N. R. et al. Molecular mechanism of GPCR-mediated arrestin activation. Nature 557, 452–456 (2018).
Liu, P. et al. The structural basis of the dominant negative phenotype of the Gαi1β1γ2 G203A/A326S heterotrimer. Acta Pharmacol. Sin. 37, 1259–1272 (2016).
Mastronarde, D. N. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 152, 36–51 (2005).
Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290–296 (2017).
Pettersen, E. F. et al. UCSF Chimera—a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612 (2004).
Pettersen, E. F. et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 30, 70–82 (2021).
Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126–2132 (2004).
Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213–221 (2010).
Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D Biol. Crystallogr. 66, 12–21 (2010).
Stoddart, L. A., Smith, N. J., Jenkins, L., Brown, A. J. & Milligan, G. Conserved polar residues in transmembrane domains V, VI, and VII of free fatty acid receptor 2 and free fatty acid receptor 3 are required for the binding and function of short chain fatty acids. J. Biol. Chem. 283, 32913–32924 (2008).
Bolognini, D. et al. Chemogenetics defines receptor-mediated functions of short chain free fatty acids. Nat. Chem. Biol. 15, 489–498 (2019).
Glide Release 2021-3 (Schrödinger, 2021).
Maestro Release 2021-3 (Schrödinger, 2021).
AMBER 2023 (Univ. California, San Francisco, 2023).
Humphrey, W., Dalke, A. & Schulten, K. VMD: visual molecular dynamics. J. Mol. Graph. 14, 33–38 (1996).
Doerr, S., Harvey, M. J., Noe, F. & De Fabritiis, G. HTMD: high-throughput molecular dynamics for molecular discovery. J. Chem. Theory Comput. 12, 1845–1852 (2016).
Lee, J. et al. CHARMM-GUI supports the Amber force fields. J. Chem. Phys. 153, 035103 (2020).
AMBER 2020 (Univ. California, San Francisco, 2020).
Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926–935 (1983).
Tian, C. et al. ff19SB: amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution. J. Chem. Theory Comput. 16, 528–552 (2020).
Dickson, C. J., Walker, R. C. & Gould, I. R. Lipid21: complex lipid membrane simulations with AMBER. J. Chem. Theory Comput. 18, 1726–1736 (2022).
He, X., Man, V. H., Yang, W., Lee, T. S. & Wang, J. A fast and high-quality charge model for the next generation general AMBER force field. J. Chem. Phys. 153, 114502 (2020).
Gowers, R. J et al. MDAnalysis: A Python package for the rapid analysis of molecular dynamics simulations. In Proc. 15th Python in Science Conference (eds Benthall, S. & Rostrup, S.) 98–105 (SciPy, 2016).
Michaud-Agrawal, N., Denning, E. J., Woolf, T. B. & Beckstein, O. MDAnalysis: a toolkit for the analysis of molecular dynamics simulations. J. Comput. Chem. 32, 2319–2327 (2011).
Pedregosa, F. et al. Scikit-learn: machine learning in Python. J. Mach. Learn. Res. 12, 2825–2830 (2011).
Zhang, X. et al. Pro-phagocytic function and structural basis of GPR84 signaling. Nat. Commun. 14, 5706 (2023).
Rodriguez-Espigares, I. et al. GPCRmd uncovers the dynamics of the 3D-GPCRome. Nat. Methods 17, 777–787 (2020).
